← Back to Search

Other

Spinal vs General Anesthesia for Tubal Ligation

N/A
Recruiting
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the surgery
Awards & highlights

Study Summary

This trial will compare anesthesia types for a tubal sterilization surgery, to see which has fewer complications, less pain and nausea, and a faster recovery. #medicalresearch

Who is the study for?
This trial is for individuals aged 21 or older who identify as cis-female or gender non-conforming with female reproductive organs, seeking permanent sterilization but not due to urgent conditions. They should be at least 6 weeks postpartum, in good health (ASA I or II), and appropriate for vNOTES surgery. Exclusions include those with certain complex medical histories, recent surgeries, severe spinal issues affecting anesthesia placement, and high-risk ASA classifications.Check my eligibility
What is being tested?
The study is examining the differences between using spinal anesthesia versus general anesthesia during vNOTES tubal sterilization. It aims to see which method leads to fewer complications during surgery, less pain after surgery, reduced nausea and vomiting post-operation, and a quicker recovery time allowing patients to leave the hospital sooner.See study design
What are the potential side effects?
Potential side effects of spinal anesthesia may include lower back pain, headaches, difficulty urinating or low blood pressure. General anesthesia might cause nausea, vomiting, sore throat from the breathing tube used during surgery or confusion upon waking up.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of perioperative complications performing VNOTES tubal sterilization with Spinal Anesthesia
Secondary outcome measures
Compare time until PACU discharge-to-home readiness between patients
Occurrence of postoperative nausea/vomiting
Rate of post-operative pain between patients

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Spinal AnesthesiaExperimental Treatment1 Intervention
This arm will receive spinal anesthesia for vNOTES surgery.
Group II: General AnesthesiaActive Control1 Intervention
This arm will receive general anesthesia for vNOTES surgery.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Spinal Anesthesia
2014
Completed Phase 4
~2780

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
463 Previous Clinical Trials
169,230 Total Patients Enrolled

Media Library

General Anesthesia (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05688943 — N/A
Anesthesia Research Study Groups: General Anesthesia, Spinal Anesthesia
Anesthesia Clinical Trial 2023: General Anesthesia Highlights & Side Effects. Trial Name: NCT05688943 — N/A
General Anesthesia (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05688943 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many subjects are being admitted to this experiment?

"Yes, the updated information on clinicaltrials.gov shows that this trail is still recruiting patients who fit its criteria. It was initially announced on March 1st 2023 and has been edited recently on May 20th of the same year. This study requires 40 participants from a single medical site."

Answered by AI

Is this medical experiment actively soliciting participants?

"According to clinicaltrials.gov, this medical study is currently accepting participants. The trial was first published on March 1st 2023 and has been updated as recently as May 20th 2023."

Answered by AI
~19 spots leftby Apr 2025